PT991409E - Composicoes farmaceuticas de libertacao controlada contendo tiagabina - Google Patents

Composicoes farmaceuticas de libertacao controlada contendo tiagabina

Info

Publication number
PT991409E
PT991409E PT98937738T PT98937738T PT991409E PT 991409 E PT991409 E PT 991409E PT 98937738 T PT98937738 T PT 98937738T PT 98937738 T PT98937738 T PT 98937738T PT 991409 E PT991409 E PT 991409E
Authority
PT
Portugal
Prior art keywords
hours
tiagabine
compositions
preparation
therapeutically effective
Prior art date
Application number
PT98937738T
Other languages
English (en)
Portuguese (pt)
Inventor
Maurice Joseph Anthony Clancy
Michelle Caulfield
Kenneth Iain Cumming
Original Assignee
Elan Corp Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26320083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT991409(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IE19970588A external-priority patent/IE970588A1/en
Application filed by Elan Corp Plc filed Critical Elan Corp Plc
Publication of PT991409E publication Critical patent/PT991409E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
PT98937738T 1997-08-01 1998-07-30 Composicoes farmaceuticas de libertacao controlada contendo tiagabina PT991409E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5443297P 1997-08-01 1997-08-01
IE19970588A IE970588A1 (en) 1997-08-01 1997-08-08 Controlled release pharmaceutical compositions containing tiagabine

Publications (1)

Publication Number Publication Date
PT991409E true PT991409E (pt) 2002-06-28

Family

ID=26320083

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98937738T PT991409E (pt) 1997-08-01 1998-07-30 Composicoes farmaceuticas de libertacao controlada contendo tiagabina

Country Status (10)

Country Link
EP (1) EP0991409B1 (enExample)
JP (1) JP2001511450A (enExample)
AT (1) ATE212550T1 (enExample)
AU (1) AU8643698A (enExample)
CA (1) CA2299464C (enExample)
DE (1) DE69803670T2 (enExample)
DK (1) DK0991409T3 (enExample)
ES (1) ES2172179T3 (enExample)
PT (1) PT991409E (enExample)
WO (1) WO1999006045A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
AU2002325404B2 (en) * 1998-01-22 2006-02-02 Abbott Laboratories Extended Release Tiagabine Formulations with Reduced Side-effects
RU2220715C2 (ru) * 1999-08-04 2004-01-10 Яманоути Фармасьютикал Ко., Лтд. Стабильная пероральная, образующая гидрогель, фармацевтическая композиция, способ ее получения, способ предотвращения изменений высвобождения лекарственного средства, способ увеличения физической стабильности пероральной композиции
KR100510270B1 (ko) * 2002-11-29 2005-08-26 센츄론(주) 펠렛타이저를 이용한 서방성 제제의 제조방법
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
EP1603540A2 (en) * 2003-03-14 2005-12-14 Nirmal Mulye A process for preparing sustained release tablets
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
EP3878445A3 (en) 2013-06-05 2021-10-27 Synchroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
PT830132E (pt) * 1995-05-05 2002-07-31 Novo Nordisk As Composicao farmaceutica contendo hidrocloruro de tiagabina como ingrediente activo e seu processo de preparacao
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
JP2000511538A (ja) * 1996-05-24 2000-09-05 スミスクライン・ビーチャム・コーポレイション 鎮咳剤としてのｇａｂａ取り込み阻害剤の使用
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders

Also Published As

Publication number Publication date
ATE212550T1 (de) 2002-02-15
WO1999006045A1 (en) 1999-02-11
DK0991409T3 (da) 2002-03-25
EP0991409B1 (en) 2002-01-30
CA2299464C (en) 2009-02-17
DE69803670D1 (de) 2002-03-14
AU8643698A (en) 1999-02-22
ES2172179T3 (es) 2002-09-16
JP2001511450A (ja) 2001-08-14
DE69803670T2 (de) 2002-11-21
CA2299464A1 (en) 1999-02-11
EP0991409A1 (en) 2000-04-12

Similar Documents

Publication Publication Date Title
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
GEP20043161B (en) Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
BR0014383A (pt) Composições de liberação controlada compreendendo nimesulida
MY115662A (en) Novel compounds with analgesic effect
DK0688214T3 (da) Fremgangsmåder til inhibering af knogletab med 3,4-diarylchroman
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
CO5251419A1 (es) Composiciones nanoparticuladas de eplerenona
PT797991E (pt) Formulacao com libertacao prolongada contendo venlafaxina
WO2004032909A3 (en) Stabilized pharmaceutical composition containing basic excipients
DK0642344T3 (da) Stabilt tørt pulver af hydratiseret cephalosporin til oral suspensionsformulering.
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
TW200503775A (en) Pharmaceutical composition and method for treating
PT1051159E (pt) Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose
PT991409E (pt) Composicoes farmaceuticas de libertacao controlada contendo tiagabina
FI933975A0 (fi) Tabletter som kontrollerat avgiver naproxen
BR0014440A (pt) Formulações de liberação controlada oral
NO982863L (no) Nye forbindelser med analgetisk effekt
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
DK0946585T3 (da) Steroidforbindelser substitueret i stilling 11, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
MXPA02012957A (es) Formulacion nueva.
MXPA04007560A (es) Formulaciones orales de trimetobenzamida y metodos para usar las mismas.
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina
ES2165734T3 (es) Composiciones basadas en pentoxifilina y anticitoquina.
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer